Ascendis Pharma A/S announced that it has granted Novo Nordisk A/S an exclusive worldwide license to the TransCon technology platform to develop, manufacture and commercialize Novo Nordisk proprietary ...
Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.
The pact will focus on the TransCon technology platform to develop, manufacture, and commercialize Novo Nordisk proprietary products for metabolic diseases (including obesity and type 2 diabetes ...
The US District Court for the District of Kansas on Nov. 1 rejectedLyft’s argument it’s just a service matching riders and drivers and can’t be sued for product liability. Under the facts alleged, ...
Cambridge Cognition Addressing Inconsistencies in CNS Clinical Trials with Advanced Quality Review Solutions Presentation of new data demonstrates effectiveness of proprietary AQUA Cambridge Cognition ...